Robert Chess's Net Worth

$19.3 Million

Estimate Recalculated Nov 11, 2024 01:32PM EST

Who is Robert Chess

Robert Chess has an estimated net worth of $19.3 Million. This is based on reported shares across multiple companies, which include COTHERIX INC, Twist Bioscience Corp, NEKTAR THERAPEUTICS, and PHARSIGHT CORP.

SEC CIK

Robert Chess's CIK is 0001227886

Past Insider Trading and Trends

2004 was Robert Chess's most active year for acquiring shares with 16 total transactions. Robert Chess's most active month to acquire stocks was the month of August. 2021 was Robert Chess's most active year for disposing of shares, totalling 28 transactions. Robert Chess's most active month to dispose stocks was the month of February. 2006 saw Robert Chess paying a total of $2,525,930.55 for 224,115 shares, this is the most they've acquired in one year. In 2004 Robert Chess cashed out on 521,059 shares for a total of $7,473,535.42, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COTHERIX INC

Investor
Updated Jan 10, 2007
Form 4
-100.00%
-60.60K
$4.59
-$390.14K
Jan 10, 2007
Disposition
Jan 09
Form 4
9.09K
Jan 05, 2007
9.09K
Grant
Jan 03
Form 4
6.06K
Jan 19, 2006
6.06K
Grant
Jan 03
Form 4
6.06K
Jan 03, 2005
6.06K
Grant
Jan 03
Form 3
Oct 15, 2004
Showing 5 results

Twist Bioscience Corp

Investor
Updated Feb 09, 2024
Form 4
2.73%
1.71K
$34.98
-$143.78K
Feb 09, 2024
64.17K
Grant
Feb 06 - Feb 08
Form 4
15.14%
8.21K
Feb 09, 2023
62.46K
Grant
Feb 07
Form 4
6.88%
3.49K
Feb 10, 2022
54.25K
Grant
Feb 08
Form 4
-0.50%
-253.00
$58.88
-$14.90K
Feb 08, 2022
50.76K
Sale
Feb 04
Form 4
-7.27%
-4.00K
$120.15
-$480.61K
Nov 03, 2021
51.01K
Sale
ScheduledNov 01
Form 4
-6.30%
-3.70K
$120.15
-$444.54K
Oct 25, 2021
55.01K
Sale
ScheduledOct 21
Form 4
-0.51%
-300.00
$120.00
-$36.00K
Oct 21, 2021
58.71K
Sale
ScheduledOct 19
Form 4
-6.35%
-4.00K
$120.23
-$480.91K
Sep 14, 2021
59.01K
Sale
ScheduledSep 10
Form 4
-5.97%
-4.00K
$125.91
-$503.65K
Jul 14, 2021
63.01K
Sale
ScheduledJul 12
Form 4
-5.63%
-4.00K
$120.10
-$480.41K
Jun 25, 2021
67.01K
Sale
ScheduledJun 23
Form 4/A
11.30K
Mar 05, 2021
11.30K
Grant
Feb 04
Form 4/A
10.59K
Mar 05, 2021
10.59K
Grant
Jul 23
Form 4
-0.98%
-706.00
$159.54
-$112.64K
Feb 09, 2021
71.01K
Sale
ScheduledFeb 05
Form 4
2.05%
1.46K
Feb 05, 2021
72.69K
Grant
Feb 03
Form 4
10.11%
7.06K
Feb 06, 2020
76.88K
Grant
Feb 04
Form 4
5.59K
Oct 09, 2019
5.59K
Grant
Jul 23
Form 3
Oct 30, 2018
69.82K
Showing 17 results

NEKTAR THERAPEUTICS

Chairman the Board
Updated Jun 14, 2024
Form 4
-7.10%
-19.50K
$1.20
-$23.40K
Jun 14, 2024
261.57K
Sale
Jun 14
Form 4
26.25%
74.80K
$0.67
-$6.83K
Sep 20, 2023
366.07K
Grant
Sep 22 - Sep 19
Form 4
-2.19%
-5.10K
$3.19
-$16.27K
Sep 26, 2022
291.27K
Sale
ScheduledSep 22
Form 4
13.72%
30.60K
Sep 20, 2022
316.77K
Grant
Sep 16
Form 4
9.48%
26.00K
$17.94
-$82.52K
Sep 24, 2021
306.57K
Grant
ScheduledSep 22
Form 4
-6.25%
-18.28K
$14.91
-$40.42K
Sep 10, 2021
280.57K
Sale
ScheduledSep 08 - Sep 09
Form 4
Aug 26, 2021
280.57K
Grant
Aug 24
Form 4
-1.88%
-5.72K
$15.31
-$17.20K
Jul 22, 2021
298.85K
Sale
ScheduledJul 20 - Jul 22
Form 4
-2.56%
-8.00K
$16.57
-$44.32K
May 14, 2021
304.57K
Sale
ScheduledMay 12
Form 4
-2.50%
-8.00K
$16.39
-$41.44K
Apr 16, 2021
312.57K
Sale
ScheduledApr 14
Form 4
-1.92%
-5.50K
$17.75
-$97.62K
Sep 25, 2020
280.57K
Sale
ScheduledSep 25
Form 4/A
9.86%
27.30K
Sep 25, 2020
304.27K
Grant
Sep 22
Form 4
9.86%
27.30K
Sep 24, 2020
304.27K
Grant
Sep 22
Form 4
-2.81%
-8.00K
$13.89
-$74.32K
Sep 10, 2020
276.97K
Sale
ScheduledSep 08
Form 4
-2.73%
-8.00K
$16.91
-$122.72K
Jul 10, 2020
284.97K
Sale
ScheduledJul 08
Form 4
-7.57%
-24.00K
$13.81
-$220.93K
Apr 17, 2020
292.97K
Sale
ScheduledApr 15
Form 4
-7.39%
-24.00K
$13.01
-$208.24K
Mar 13, 2020
300.97K
Sale
ScheduledMar 11
Form 4
-7.21%
-24.00K
$16.37
-$261.92K
Feb 14, 2020
308.97K
Sale
ScheduledFeb 12
Form 4
-1.42%
-4.00K
$17.99
-$71.96K
Oct 01, 2019
276.97K
Sale
ScheduledSep 27
Form 4
7.10%
19.50K
Sep 27, 2019
293.97K
Grant
Sep 25
Form 4
5.28%
14.25K
Oct 01, 2018
283.97K
Grant
Sep 27
Form 4
-1.64%
-4.50K
$56.81
-$255.64K
Sep 21, 2018
269.72K
Sale
ScheduledSep 19
Form 4
-3.52%
-10.00K
$34.71
-$409.00K
Jun 07, 2018
274.22K
Sale
ScheduledJun 05
Form 4
-8.08%
-25.00K
$45.80
-$1.85M
May 04, 2018
284.22K
Sale
ScheduledMay 03
Form 4
-7.48%
-25.00K
$50.47
-$2.08M
Apr 09, 2018
309.22K
Sale
ScheduledApr 06
Form 4
-2.28%
-6.40K
$21.72
-$139.01K
Sep 25, 2017
274.22K
Sale
ScheduledSep 21
Form 4
11.60%
31.50K
Sep 21, 2017
303.12K
Grant
Sep 19
Form 4
-1.81%
-5.00K
$14.08
-$57.10K
May 17, 2017
271.62K
Sale
ScheduledMay 15
Form 4
-1.78%
-5.00K
$13.54
-$51.75K
Apr 19, 2017
276.62K
Sale
ScheduledApr 17
Form 4
-1.74%
-5.00K
$11.89
-$35.20K
Mar 16, 2017
281.62K
Sale
ScheduledMar 14
Form 4
10.62%
28.00K
Sep 23, 2016
291.62K
Grant
Sep 21
Form 4
-4.35%
-12.00K
$19.21
-$230.52K
Sep 19, 2016
263.62K
Sale
ScheduledSep 15
Form 4
-1.88%
-5.00K
$11.21
-$60.55K
Aug 03, 2016
260.62K
Sale
ScheduledAug 01
Form 4
-1.85%
-5.00K
$9.63
-$44.75K
Jul 05, 2016
265.62K
Sale
ScheduledJul 01
Form 4
-1.81%
-5.00K
$10.33
-$51.75K
Jun 03, 2016
270.62K
Sale
ScheduledJun 01
Form 4
27.50K
Sep 17, 2015
27.50K
Grant
Sep 15
Form 4
-5.44%
-15.00K
$10.31
-$45.00K
Jun 23, 2015
260.62K
Sale
ScheduledJun 19
Form 4
-10.17%
-29.50K
$15.29
-$2.95K
Dec 31, 2014
260.62K
Sale
ScheduledDec 29
Form 4
45.00K
Sep 25, 2014
45.00K
Grant
Sep 23
Form 4
40.00K
Sep 23, 2013
40.00K
Grant
Sep 19
Form 4
40.00K
Sep 18, 2012
40.00K
Grant
Sep 14
Form 4
-8.43%
-24.00K
$7.31
-$57.12K
Jul 17, 2012
260.62K
Sale
ScheduledJul 13
Form 4
30.00K
$5.14
$154.20K
Sep 15, 2011
30.00K
Grant
Sep 13
Form 4
-1.73%
-4.50K
$9.00
-$40.50K
Mar 09, 2011
255.71K
Sale
ScheduledMar 07 - Mar 08
Form 4/A
30.00K
$14.26
$427.80K
Sep 17, 2010
30.00K
Grant
Sep 14
Form 4
30.00K
$14.05
$421.50K
Sep 16, 2010
30.00K
Grant
Sep 14
Form 4
-11.14%
-35.00K
$10.04
-$273.91K
May 12, 2010
279.13K
Sale
ScheduledMay 10
Form 4/A
65.00K
$4.19
$126.05K
Sep 22, 2009
20.00K
Grant
Sep 15
Form 4
20.00K
$4.19
$125.60K
Sep 17, 2009
20.00K
Grant
Sep 15
Form 4
20.00K
$2.58
$77.30K
Dec 04, 2008
20.00K
Grant
Dec 02
Form 4
Nov 18, 2008
255.12K
Options
Nov 14
Form 4
2.06%
20.00K
$4.41
$132.20K
Sep 21, 2007
991.63K
Grant
Sep 17 - Sep 19
Form 4
-6.85%
-17.70K
$12.23
-$216.47K
Mar 22, 2007
240.79K
Sale
ScheduledMar 22
Form 4
$0.01
Mar 21, 2007
258.49K
Acq/Dis
Mar 19
Form 4/A
76.60%
25.00K
$0.01
$250.00
Jan 09, 2007
57.64K
Grant
Jun 30
Form 4
3.26%
38.41K
$11.07
$397.59K
Jan 09, 2007
1.22M
Grant
Jan 03 - Jan 08
Form 4
$0.01
Jan 05, 2007
212.21K
Acq/Dis
Jan 03
Form 4
8.33%
75.00K
$9.18
$917.25K
Jun 30, 2006
975.60K
Grant
Jun 30
Form 4
-1.04%
-2.21K
$4.96
-$43.75K
Mar 07, 2006
210.00K
Sale
Mar 03 - Mar 07
Form 4/A
6.66%
56.25K
$10.70
$801.94K
Mar 07, 2006
900.60K
Grant
Feb 24
Form 4
6.66%
56.25K
$10.76
$806.44K
Feb 24, 2006
900.60K
Grant
Feb 24
Form 4
Mar 16, 2005
221.65K
Acq/Dis
Mar 14
Form 4/A
16.67K
Mar 16, 2005
16.67K
Grant
Mar 04
Form 4
3.03%
25.00K
$18.08
$452.00K
Feb 14, 2005
850.46K
Grant
Feb 12
Form 4/A
5.87%
16.67K
Dec 07, 2004
300.37K
Grant
Mar 04
Form 4
-2.20%
-56.60K
$17.80
-$835.15K
Mar 10, 2004
2.52M
Sale
Mar 08
Form 4
-2.58%
-100.00K
$15.43
-$1.79M
Mar 09, 2004
3.77M
Sale
Mar 05
Form 4
-0.98%
-50.00K
$13.18
-$1.54M
Mar 08, 2004
5.08M
Sale
Mar 04
Form 4
-0.27%
-5.10K
$12.48
-$85.22K
Feb 23, 2004
1.88M
Sale
Feb 19
Form 4
-1.33%
-68.30K
$12.38
-$1.15M
Feb 12, 2004
5.07M
Sale
Feb 10
Form 4
-0.17%
-2.80K
$9.78
-$29.22K
Oct 17, 2003
1.66M
Sale
Oct 15
Form 4
-0.17%
-2.80K
$9.78
-$29.22K
Oct 16, 2003
1.66M
Sale
Oct 14
Form 4
-1.85%
-69.40K
$9.36
-$845.04K
Oct 14, 2003
3.68M
Sale
Oct 13
Showing 73 results

PHARSIGHT CORP

Investor
Updated Aug 12, 2005
Form 4
10.00K
Aug 12, 2005
10.00K
Grant
Aug 11
Form 4
10.00K
Sep 20, 2004
10.00K
Grant
Aug 13
Form 4
Jun 18, 2003
Showing 3 results